Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Selection of L74V mutation in reverse transcriptase of HIV-1 subtype D by a tenofovir DF-lamivudine based regimen.

AIDS (London, England) - 30 Nov 2007

Tamalet Catherine, Tomei Christelle, Henry Mireille, Solas Caroline, Villacian Jorge, Colson Philippe

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenine
Share to Anti-HIV Agents
Share to Antiretroviral Therapy, Highly Active
Share to HIV Reverse Transcriptase

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Lamivudine

Share to Organophosphonates

Share to Reverse Transcriptase Inhibitors

Share to Tenofovir

Source

Identifiers

PMID: 18025898
DOI: 10.1097/QAD.0b013e32827b1499

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Selection of L74V mutation in reverse transcriptase of HIV-1 subtype D by a tenofovir DF-lamivudine based regimen.PMID 18025898Read ↗

Selection of K65R mutation in HIV-2-infected patients receiving tenofovir-containing regimen.Semantic proximity Read ↗

Selection of a rare resistance profile in an HIV-1-infected patient exhibiting a failure to an antiretroviral regimen including tenofovir DF.Semantic proximity Read ↗

Risk factors for selection of the L74I reverse transcriptase mutation in human immunodeficiency virus type 1-infected patients.Semantic proximity Read ↗

Human immunodeficiency virus type 1 reverse transcriptase mutation selection during in vitro exposure to tenofovir alone or combined with abacavir or lamivudine.Semantic proximity Read ↗

Impact of a treatment including tenofovir plus didanosine on the selection of the 65R mutation in highly drug-experienced HIV-infected patients.Semantic proximity Read ↗

Selection of the R263K mutation to dolutegravir in cerebrospinal fluid HIV-1 virus in one patient with HIV-associated neurocognitive disorders.Semantic proximity Read ↗

Selection of the Q148R integrase inhibitor resistance mutation in a failing raltegravir containing regimen.Semantic proximity Read ↗

Ultra-rapid selection of the N74D capsid inhibitor resistance mutation after 3 weeks on lenacapavir.Semantic proximity Read ↗

Molecular impact of the M184V mutation in human immunodeficiency virus type 1 reverse transcriptase.Semantic proximity Read ↗

Infection with the frequently transmitted HIV-1 M41L variant has no influence on selection of tenofovir resistance.Semantic proximity Read ↗

Selection of hepatitis B virus polymerase mutations in HIV-coinfected patients treated with tenofovir.Semantic proximity Read ↗

Comparative selection of the K65R and M184V/I mutations in human immunodeficiency virus type 1-infected patients enrolled in a trial of first-line triple-nucleoside analog therapy (Tonus IMEA 021).Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.